Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study

K. Draaisma, A. Chatzipli, M. Taphoorn, M. Kerkhof, A. Weyerbrock, M. Sanson, A. Hoeben, S. Lukacova, G. Lombardi, S. Leenstra, M. Hanse, R. Fleischeuer, C. Watts, J. McAbee, N. Angelopoulos, T. Gorlia, V. Golfinopoulos, J.M. Kros, R.G.W. Verhaak, V. BoursM.J. van den Bent, U. McDermott, P.A. Robe, P.J. French

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)81-+
Number of pages84
JournalJournal of Clinical Oncology
Volume38
Issue number1
DOIs
Publication statusPublished - 1 Jan 2020

Keywords

  • clonal evolution
  • expression
  • methylation
  • mgmt
  • origin
  • paired primary
  • radiotherapy
  • reveals
  • temozolomide
  • tumors
  • METHYLATION
  • MGMT
  • CLONAL EVOLUTION
  • TUMORS
  • TEMOZOLOMIDE
  • ORIGIN
  • RADIOTHERAPY
  • EXPRESSION
  • PAIRED PRIMARY
  • REVEALS

Cite this